The successful candidate will hold a clinical non-tenure track position with the Faculty of Medicine’s Department of Medicine, its affiliated hospital Bruyère Health, and its affiliated research institute (Bruyère Health Research Institute -BHRI), with the potential for other cross-appointments. The candidate will be a member of the Brain-Heart Interconnectome (BHI). The BHI is a ground-breaking interdisciplinary research program aimed at accelerating prevention, detection, treatment and care of interconnected brain and heart disorders through research co-produced with patients and other knowledge users. The Chairholder will hold, or will be eligible to hold a licence to practice medicine with the College of Physician and Surgeons of Ontario (CPSO).
We are interested in attracting early-career candidates with demonstrated strengths and recognition in vascular cognitive impairment. The candidate will have a strong understanding of cerebrovascular disease mechanisms, small vessel disease, stroke-related dementia, and neurovascular disfunction. Research expertise in healthy brain aging and dementia prevention is highly valued, including for example, the relationship of cerebrovascular disease on the development of cognitive impairment and the impact of vascular risk factor identification and management on reducing the risk of cognitive decline. The candidate will be a team builder with strong potential to develop and foster local, pan Canadian and international collaborations. They will also be committed to training the next generation of researchers and using a research co-production approach involving patients and other users.
The successful candidate will become an integral part of a dynamic, collaborative, and interconnected research environment in the Faculty of Medicine and its associated Research Institutes and as part of the multi-institutional and transdisciplinary Brain-Heart Interconnectome. As Chair, the researcher will also directly contribute to development of and leadership in running pharmacological and non-pharmacological clinical trial interventions designed to extend longevity and/or quality of life of dementia patients.
Tier 2 Chairs, tenable for five years and renewable once, are for exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field. For each Tier 2 Chair, the Canada Research Chairs (CRC) Program allocates to institutions $100,000 annually for five years, with an additional $20,000 annual research stipend for first-term Tier 2 Chairs.
Candidates should, at a minimum, be assistant or associate professors, or possess the necessary qualifications to be appointed to these levels. Candidates who are more than 10 years from their highest degree must contact the University of Ottawa directly for questions related to their potential eligibility for a Tier 2 Chair. The institution may nominate a professor or a researcher who is more than 10 years from their highest degree at the time of nomination and has experienced legitimate career interruptions (see acceptable justifications). In such cases, the institution must submit to the Secretariat a formal justification (using the Tier 2 Justification Screening Form), explaining why the nominee is still considered to be an emerging scholar.
The University recognizes the legitimate impact that leaves (e.g., parental leave, leave due to illness) can have on a candidate’s record of research achievement and that these leaves will be taken into careful consideration during the assessment process. New CRC nominees are also eligible for infrastructure support from the Canada Foundation for Innovation (CFI) to help acquire state-of-the-art equipment essential to their work.